5AM Opportunities I (GP), LLC

10% owner at ELVN; 10% owner at Pear Therapeutics, Inc.; 10% owner at scPharmaceuticals Inc., and 1 more

Sold, on record
$19M
Dollars the filings state
Form 4 sales
5
Latest Jan 31, 2024
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale APREUnusual
    Jun 16 2020

    Sold 140,000 shares at $33.30 ($4.7M)

    5AM Opportunities I (GP), LLC, 10% owner

    Sold 30.9% of holdings ($15.1M position)313,497 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale APREUnusual
    Oct 5 +111 days

    Sold 175,000 shares at $25.30 ($4.4M)

    5AM Opportunities I (GP), LLC, Other

    Sold 55.8% of holdings ($7.9M position)138,497 shares leftFiling

  3. 3 Form 4 sale scPharmaceuticals Inc.Unusual
    Apr 11 +553 days

    Sold 270,000 shares at $5.00 ($1.4M)

    5AM Opportunities I (GP), LLC, 10% owner

    Sold 33.4% of holdings ($4M position)537,301 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Pear Therapeutics, Inc.Unusual
    Sep 16 +158 days

    Sold 558,168 shares at $1.88 ($1M)

    5AM Opportunities I (GP), LLC, 10% owner

    Sold 50.8% of holdings ($2.1M position)541,235 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale ELVNUnusual
    Jan 31 +502 days

    Sold 500,000 shares at $15.00 ($7.5M)

    5AM Opportunities I (GP), LLC, 10% owner

    No 10b5-1 planSold 39.3% of holdings ($19.1M position)771,983 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by 5AM Opportunities I (GP), LLC
Source
Jan 31, 2024ELVN10% ownerForm 4 sale500,000$7.5M39.3%UnusualSEC
Sep 16, 2022Pear Therapeutics, Inc.10% ownerForm 4 sale558,168$1M50.8%UnusualSEC
Apr 11, 2022scPharmaceuticals Inc.10% ownerForm 4 sale270,000$1.4M33.4%UnusualSEC
Oct 5, 2020APREOtherForm 4 sale175,000$4.4M55.8%UnusualSEC
Jun 16, 2020APRE10% ownerForm 4 sale140,000$4.7M30.9%UnusualSEC